Skip to main content
. Author manuscript; available in PMC: 2007 Aug 15.
Published in final edited form as: Drug Discov Today Dis Models. 2006;3(1):97–103. doi: 10.1016/j.ddmod.2006.03.014

Figure 1.

Figure 1

Reconstitution of NOD/SCID mice with human hematopoietic progenitor cells. Irradiated NOD/SCID mice are injected with CD34+ cells purified from human umbilical cord blood. Six to 8 weeks later reconstitution levels of human CD45+ cells (panleukocyte marker) and CD11c+/CD123+ cells (DC marker) are determined by flow cytometry. Details are provided in Refs [41,42].